Turnover: 42 million (2022)
Country: France
Microbiotic drugs specialist founded in 1951
News
Microbiota drugs: Biose industrie to double its production capacity in the Cantal region of France 19/10/2023
- Specialist in microbiota-based drugs
- Current investment plan of 80 million euros at the Aurillac site
- 40 million euros have already been invested since 2020.
- Production capacity is currently being increased to reach 32,000 liters of fermentation volume in four years' time.
- Biose Industrie's workforce has grown to over 500 employees.
- The current annual production capacity of the Aurillac plant is 100 million capsules and 10 million sachets.
- The family firm's sales target was 23 million euros in 2020, 33 million in 2021 and 42 million last year.
- Biose Industrie's customers are mainly major pharmaceutical and biotech companies, active worldwide.
> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)
Sector-GPT est la première IA dédiée aux informations sectorielles.